Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. | CFO and Secretary | Common Stock | 248K | $3.25M | $13.14 | Jul 11, 2024 | Direct |
Mineralys Therapeutics, Inc. | CFO and Secretary | Stock Option | 200K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MLYS | Mineralys Therapeutics, Inc. | Jul 11, 2024 | 1 | -$141K | 4 | Jul 12, 2024 | CFO and Secretary |
MLYS | Mineralys Therapeutics, Inc. | Jun 11, 2024 | 1 | -$1.25M | 4 | Jun 13, 2024 | CFO and Secretary |
MLYS | Mineralys Therapeutics, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | CFO and Secretary |
MLYS | Mineralys Therapeutics, Inc. | Mar 17, 2023 | 1 | $0 | 4 | Mar 21, 2023 | CFO and Secretary |
MLYS | Mineralys Therapeutics, Inc. | Feb 14, 2023 | 1 | $100K | 4 | Feb 16, 2023 | CFO, Chief Bus. Off. and Secy. |
MLYS | Mineralys Therapeutics, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | CFO, Chief Bus. Off. and Secy. |
MLYS | Mineralys Therapeutics, Inc. | Feb 9, 2023 | 0 | $0 | 3 | Feb 9, 2023 | CFO, Chief Bus. Off. and Secy. |